The cosmetic tissue augmentation (CTA) product,of Anika Therapeutics, Inc has been approved by Food and Drug Administration (FDA). However the final approval is pending for December,2006. Anika is planning to release the enhanced version of CTA product by mid of 2007.

CTA Features
a. Cosmetic tissue augmentation (CTA) product is made of Anika's chemically modified hyaluronic acid proprietary technology, incorporating a local anesthetic named lidocaine.
b. It is an injectable soft tissue filler for scar remediation, facial wrinkles and lip augmentation.